Business Description
Talis Biomedical Corp
NAICS : 339112
SIC : 3845
ISIN : US87424L2079
Share Class Description:
TLIS: Ordinary SharesDescription
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.18 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.39 | |||||
| Debt-to-EBITDA | -0.35 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -12.14 | |||||
| Beneish M-Score | -7.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 19.2 | |||||
| 3-Year EPS without NRI Growth Rate | 21.1 | |||||
| 3-Year FCF Growth Rate | 25.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.89 | |||||
| 9-Day RSI | 41.97 | |||||
| 14-Day RSI | 44.6 | |||||
| 6-1 Month Momentum % | -80.21 | |||||
| 12-1 Month Momentum % | -79.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.76 | |||||
| Quick Ratio | 7.76 | |||||
| Cash Ratio | 7.3 | |||||
| Days Sales Outstanding | 175.2 | |||||
| Days Payable | 50866.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.6 | |||||
| Shareholder Yield % | 195.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 93.33 | |||||
| Operating Margin % | -18374 | |||||
| Net Margin % | -17008.67 | |||||
| FCF Margin % | -13411.67 | |||||
| ROE % | -72.45 | |||||
| ROA % | -53.13 | |||||
| ROIC % | -268.84 | |||||
| ROC (Joel Greenblatt) % | -397.79 | |||||
| ROCE % | -63.21 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.3 | |||||
| PB Ratio | 0.06 | |||||
| Price-to-Tangible-Book | 0.06 | |||||
| EV-to-EBIT | 0.69 | |||||
| EV-to-EBITDA | 0.7 | |||||
| EV-to-Revenue | -126.55 | |||||
| EV-to-FCF | 0.94 | |||||
| Price-to-Net-Current-Asset-Value | 0.08 | |||||
| Price-to-Net-Cash | 0.09 | |||||
| Earnings Yield (Greenblatt) % | 144.93 | |||||
| FCF Yield % | -1298.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TLIS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Talis Biomedical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.3 | ||
| EPS (TTM) ($) | -28.02 | ||
| Beta | 1.76 | ||
| Volatility % | 75.36 | ||
| 14-Day RSI | 44.6 | ||
| 14-Day ATR ($) | 0.070069 | ||
| 20-Day SMA ($) | 1.774875 | ||
| 12-1 Month Momentum % | -79.52 | ||
| 52-Week Range ($) | 1.37 - 9.6 | ||
| Shares Outstanding (Mil) | 1.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Talis Biomedical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Talis Biomedical Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Talis Biomedical Corp Frequently Asked Questions
What is Talis Biomedical Corp(TLIS)'s stock price today?
The current price of TLIS is $1.70. The 52 week high of TLIS is $9.60 and 52 week low is $1.37.
When is next earnings date of Talis Biomedical Corp(TLIS)?
The next earnings date of Talis Biomedical Corp(TLIS) is 2024-12-26 Est..
Does Talis Biomedical Corp(TLIS) pay dividends? If so, how much?
Talis Biomedical Corp(TLIS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers